Growth in infrastructure and process-development capabilities will be required to support the biologics market.
Victor Coker
Advertisement
Articles by Victor Coker
Advertisement
Latest Updated Articles
Biotherapeutics Outpace Conventional TherapiesPublished: March 2nd 2012 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
